Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1002 of 5804
-
New cocktail of charcoal and laxative could speed up poison recovery
Disease control Recruiting nowGastrointestinal absorption of high dose medication (toxicant) ingested under solid form for suicidal purposes, is prolonged in patients who need intensive care admission and mechanical ventilation. This is due to the large ingested amounts, slowed blood circulation in the digest…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Real-World study tracks Ravulizumab's impact on rare kidney disease
Disease control Recruiting nowThis multicenter, observational cohort study uses retrospective collection of past medical history and prospective follow-up to capture longitudinal data on the management and clinical outcomes of patients with atypical hemolytic uremic syndrome (aHUS) treated with ravulizumab as…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Smartwatch-Like device could help test DMD drugs in toddlers
Knowledge-focused Recruiting nowEvery year, 100 boys are born in the UK with a rare muscle disease called Duchenne muscular dystrophy. These boys cannot make an important muscle protein called dystrophin. They become weaker as they get older and lose the ability to walk as teenagers. This is a life-limiting con…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Virtual peer mentoring aims to boost cervical cancer screening in ethiopian HIV clinics
Knowledge-focused ENROLLING_BY_INVITATIONProject TICHILALECH ("she can" in Amharic), a five-year, implementation science study, is focused on improving cervical cancer screening, triage, and treatment and integration with human immunodeficiency virus (HIV) care at five Ethiopian hospitals, with a focus on human papillom…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Ancient herbs meet modern medicine: can Curcumin-QingDai tame UC?
Disease control Not yet recruitingThe purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-active pill), in combination with vedolizumab prescribed as standard of care for patients with ulcerative colitis (UC)..
Phase: PHASE4 • Sponsor: Ryan C Ungaro • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for rare amyloidosis: targeted drug combo enters trial
Disease control Recruiting nowThe study aims to evaluate the efficacy and safety of belantamab mafodotin in combination with cyclophosphamide, bortezomib, and dexamethasone in adult participants with newly diagnosed (ND) AL amyloidosis .
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New hope for Hard-to-Treat myeloma: early trial launches
Disease control Recruiting nowThis study will evaluate safety, pharmacokinetics (PK), clinical activity and pharmacodynamics (PD) of RO7851624 in participants with RRMM who are triple-class exposed (treated with proteasome inhibitors \[PIs\], immunomodulators \[IMiDs\], and anti-cluster of differentiation 38 …
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New MRI method could spot oral cancer early in rare disease patients
Diagnosis Recruiting nowThis study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
Sponsor: University of Minnesota • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
Bone marrow injection may offer longer hip pain relief than steroids
Symptom relief Not yet recruitingThis is a single site, randomized single blinded, two arm study researching the effects of bone marrow aspirate concentrate (BMAC) versus Triamcinolone in patients with hip osteoarthritis. The aims and hypothesis are as follows: Specific Aim 1: Evaluate the change in pain and fu…
Phase: PHASE3 • Sponsor: The Cleveland Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Could a vaccine stop Alzheimer's before it starts? new trial begins
⭐️ VACCINE ⭐️ Recruiting nowThis is a Phase 1, multicenter, randomized, double-blind, placebo-controlled, multiple dose-escalating trial to evaluate the safety, tolerability, and immune response of AV-1980R, an investigational vaccine targeting tau protein, in participants with preclinical Alzheimer's disea…
Phase: PHASE1 • Sponsor: Institute for Molecular Medicine • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 24, 2026 00:00 UTC
-
New study explores immunotherapy for rare cancers in japanese patients
Disease control Recruiting nowResearchers are looking for new ways to treat people with solid tumors, lymphomas (blood cancers), and a certain type of skin cancer. The goals of this study are to learn: * About the safety of pembrolizumab (the study medicine) and if people tolerate it * What happens to differ…
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Promising drug combo targets Hard-to-Treat brain cancers
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects best dose and effect of retifanlimab with or without difluoromethylornithine (DFMO) for the treatment of high grade gliomas that are growing, spreading, or getting worse (progressive). Immunotherapy with monoclonal antibodies, …
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Flash of hope: millisecond radiation could spare healthy skin in cancer fight
Disease control Not yet recruitingThe goal of this clinical investigation is to describe and compare the toxicity and efficacy of an experimental radiotherapy, named FLASH therapy, to conventional radiotherapy for subjects suffering from localized Cutaneous Squamous Cell Carcinoma (cSCC) and Basal Cell Carcinoma …
Phase: PHASE2 • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New shot aims to keep blood pressure in check after hospital discharge
Disease control Recruiting nowThe purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.
Phase: PHASE2 • Sponsor: Kardigan, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Virtual reality may soothe teen anxiety during clinic visits
Symptom relief Not yet recruitingThis study examines the effectiveness of virtual reality (VR) protocols based on mindfulness as a nonpharmacological approach to reduce social anxiety among adolescents. Conducted as a non-randomized, controlled, multi-center trial, the research aims to provide evidence supportin…
Phase: NA • Sponsor: Mohammed Bin Rashid University of Medicine and Health Sciences • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New surgical trick may stop spine from bending after major back surgery
Disease control Not yet recruitingPJK (proximal junctional kyphosis) at the upper end of spinal fusions after surgical correction of adult spinal deformity is not uncommon. Two-thirds of cases are observed within the first 3 months after surgery and 80% within the first 18 months. PJK is consequently a common pro…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Hard-to-Treat sarcomas? early trial launches
Disease control Recruiting nowThe main goal of this study is to test a new medicine, Risvutatug Rezetecan also called Ris-Rez. We want to see if this medicine can help people with certain types of cancer, whether its safe to use, how well people tolerate it, and how their bodies handle the drug (how its absor…
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New wound dressings aim to heal stubborn diabetic and leg ulcers
Disease control Recruiting nowCAMPR-II Trial: A multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a saline-hydrated allogeneic dual-layer amniotic membrane product or a synthetic, resorbable polymeric wound matrix to a coarsened exact matched retrospective control co…
Phase: NA • Sponsor: Capsicure, LLC • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New pill could tame phenylketonuria by blocking amino acid absorption
Disease control Recruiting nowThis study is a Phase I single ascending dose clinical trial in which healthy adult volunteers were administered single oral doses of GenSci144 tablets at different levels. It was conducted using a randomized, double-blind, placebo-controlled design, primarily to evaluate the dru…
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New cocktail of drugs takes on tough pancreatic cancer
Disease control Recruiting nowThe researchers are doing this study to find out whether ELI-002 7P in combination with mFOLFIRINOX, with or without tislelizumab, is a safe treatment approach in people who have pancreatic ductal adenocarcinoma (PDAC) with a KRAS mutation. In addition, the researchers are doing …
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC